Matthew Cooperberg

Title: The Innovations of Matthew Cooperberg

Introduction

Matthew Cooperberg is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of medical technology, particularly in the area of prostate cancer research. His work focuses on developing methods to predict the aggressiveness of prostate tumors, which can greatly aid in treatment selection for patients.

Latest Patents

Matthew Cooperberg holds a patent for a method titled "Determining risk of prostate tumor aggressiveness." This patent relates to innovative methods, computer products, and systems designed to predict the probability of prostate cancer recurrence and tumor aggressiveness in patients. The method utilizes a patient's risk profile, which includes specific copy number variations and predictive clinical factors. This groundbreaking approach can significantly enhance treatment decision-making for individuals diagnosed with prostate cancer.

Career Highlights

Cooperberg is affiliated with the University of California, where he continues to advance his research and contribute to the academic community. His work has garnered attention for its potential to improve patient outcomes in oncology. With a focus on integrating technology and medicine, he has positioned himself as a leader in his field.

Collaborations

Matthew Cooperberg has collaborated with notable colleagues, including Pamela Paris and Peter Carroll. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of better healthcare solutions.

Conclusion

Matthew Cooperberg's contributions to the field of prostate cancer research exemplify the impact of innovative thinking in medicine. His patent and ongoing work at the University of California highlight the importance of predictive methods in enhancing patient care.